肝损伤与 COVID-19：发病机制还是伴随现象？
Hepatic injury and COVID-19: pathogenic mechanisms or epiphenomena?
机构信息
Cirugía/Apoyo Investigación, Clinica Universidad de Navarra, España.
General Surgery, Clínica Universidad de Navarra, España.
出版信息
Rev Esp Enferm Dig. 2021 Jul;113(7):554-555. doi: 10.17235/reed.2021.7851/2021.
PMID:33569967
Abstract
Ampuero J et al. analyzed the relationship between liver injury and clinical progression of the disease in a meta-analysis of over 5,000 COVID-19 patients. The authors reported an association between increased aspartate aminotransferase (AST), alanine aminotransferase (ALT) and bilirubin levels with mortality, admission to Intensive Care and the development of complications, respectively.
摘要
安普尔罗等人在对超过 5000 名 COVID-19 患者的荟萃分析中分析了肝损伤与疾病临床进展之间的关系。作者报告称，天冬氨酸氨基转移酶（AST）、丙氨酸氨基转移酶（ALT）和胆红素水平升高分别与死亡率、入住重症监护病房和并发症的发展相关。
Zotero 插件